Civic AI
Procurement intelligence
Federal contract award
DEVELOPMENT OF ANTICERAMIDE TREATMENT AS A NOVEL MEDICAL COUNTERMEASURE FOR ACUTE EFFECTS OF RADIATION EXPOSURE
CERAMEDIX HOLDING, LLC · Department of Health and Human Services
- Value
- $4,223,612
- Start
- Jul 1, 2023
- End
- Jun 30, 2027
- Action date
- Mar 31, 2026
- PIID
- 75N93023C00015
- Status
- active
- NAICS
- 541714 · RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY)
- Place of performance
- NEW YORK, NY
- Award type
- DEFINITIVE CONTRACT
Description
DEVELOPMENT OF ANTICERAMIDE TREATMENT AS A NOVEL MEDICAL COUNTERMEASURE FOR ACUTE EFFECTS OF RADIATION EXPOSURE
Need modifications, related awards, and vendor peers? Open the full award workspace.